Pancytopenia in Older Adults

Introduction to Pancytopenia

The American Geriatrics Society recommends being aware that several medications commonly used in older adults can cause pancytopenia, with antibiotics like trimethoprim-sulfamethoxazole and immunosuppressants like methotrexate being among the highest risk agents 1
Azathioprine can cause severe, potentially life-threatening myelotoxicity, especially when combined with other medications, as reported by the British Journal of Dermatology 1
Minocycline and Doxycycline can cause blood abnormalities including agranulocytosis, hemolytic anemia, thrombocytopenia, leukopenia, neutropenia, pancytopenia, and eosinophilia, according to the Journal of the American Academy of Dermatology 2

Age-related physiological changes, such as decreased renal function, altered drug metabolism, and reduced bone marrow reserve, can increase the risk of pancytopenia in older adults, as stated by the European Heart Journal 3

Polypharmacy can increase the risk of pancytopenia due to drug-drug interactions, particularly when combining multiple myelosuppressive agents, as reported by the Journal of the National Comprehensive Cancer Network 4
Specific drug interactions, such as allopurinol with azathioprine, can create a high risk for severe myelotoxicity, according to the British Journal of Dermatology 1
Co-trimoxazole (TMP-SMX) with other myelosuppressive drugs can also increase the risk of pancytopenia, as stated by the British Journal of Dermatology 1

Before starting high-risk medications, a complete blood count (CBC), renal function tests, liver function tests, and assessment of concomitant medications should be performed, as recommended by the Journal of the American Academy of Dermatology 5
Regular CBC monitoring, more frequently when initiating therapy, and more vigilant monitoring for patients with risk factors, is crucial during treatment, according to the Journal of the American Academy of Dermatology 5
Medication review at every visit to identify potentially inappropriate combinations is essential, as stated by the Journal of the National Comprehensive Cancer Network 4
Dose adjustments based on age, renal function, body weight, and concomitant medications are necessary, as reported by the Mayo Clinic Proceedings 6

Immediate discontinuation of the suspected causative agent is necessary in cases of drug-induced pancytopenia, as recommended by the European Heart Journal 3
Supportive care, including blood product transfusions as needed, infection prevention and treatment, and close monitoring of blood counts for recovery, is crucial, according to the Journal of the American Academy of Dermatology 5
Consideration of hematology consultation for severe or persistent cases is essential, as stated by the Journal of the National Comprehensive Cancer Network 4

Failure to recognize drug-induced pancytopenia, inadequate monitoring, overlooking drug interactions, and delayed recognition can lead to poor outcomes in older adults, as reported by the European Heart Journal 3